Spermine and Citrate as Metabolic Biomarkers for Assessing Prostate Cancer Aggressiveness

Separating indolent from aggressive prostate cancer is an important clinical challenge for identifying patients eligible for active surveillance, thereby reducing the risk of overtreatment. The purpose of this study was to assess prostate cancer aggressiveness by metabolic profiling of prostatectomy...

Descripción completa

Detalles Bibliográficos
Autores principales: Giskeødegård, Guro F., Bertilsson, Helena, Selnæs, Kirsten M., Wright, Alan J., Bathen, Tone F., Viset, Trond, Halgunset, Jostein, Angelsen, Anders, Gribbestad, Ingrid S., Tessem, May-Britt
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3633894/
https://www.ncbi.nlm.nih.gov/pubmed/23626811
http://dx.doi.org/10.1371/journal.pone.0062375

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3633894/
https://www.ncbi.nlm.nih.gov/pubmed/23626811
http://dx.doi.org/10.1371/journal.pone.0062375

Ejemplares similares